Rainbow Children'S Medicare Limited Share Price & Stock Analysis

Rainbow Children'S Medicare Limited (NSE: RAINBOW, BSE: 543524) is a Hyderabad, Telangana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹13,010 Cr, it ranks #514 by market cap among the 6,197 Indian listed companies on FinBizNet, and #10 of 46 in Hospitals and Healthcare Centers. At ₹1,273.00 (as of 16 Nov 2026), the share price is 20.9% below its 52-week high of ₹1,610.00 and 17.4% above its 52-week low of ₹1,084.00. The share price is down 6.8% over one year and down 12.5% over three months.

Key Metrics

Current Price₹1,273.00
Market Cap₹13,010 Cr
NSE SymbolRAINBOW
BSE Code543524
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Hospitals and Healthcare Centers
P/E Ratio47.1
Return on Equity17.94%
Return on Assets9.55%
52-Week Range₹1,084.00 – ₹1,610.00
1-Year Price Change-6.8%
3-Month Price Change-12.5%
Beta (1Y)0.37
Dividend Yield0.27%
HeadquartersHyderabad, Telangana
Websitewww.rainbowhospitals.in

Latest Quarterly Results — Q2 FY27

Revenue₹548 Cr
Net Profit₹84 Cr
Net Margin15.3%
EPS (Basic)₹8.10
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Rainbow Children'S Medicare Limited Quarterly Revenue and Profit Trend

Rainbow Children'S Medicare Limited reported revenue of ₹548 Cr in Q2 FY27, up 23.2% from ₹445 Cr in Q2 FY26 and up 16.6% from ₹470 Cr in Q1 FY27. It posted a net profit of ₹84 Cr for the quarter, against a net profit of ₹76 Cr in Q2 FY26 (up 10.9%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹353 Cr (Q1 FY26) to ₹548 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹548 Cr₹84 Cr15.3%
Q1 FY27₹470 Cr₹63 Cr13.3%
Q4 FY26₹460 Cr₹78 Cr17.0%
Q3 FY26₹445 Cr₹74 Cr16.6%
Q2 FY26₹445 Cr₹76 Cr17.0%
Q1 FY26₹353 Cr₹54 Cr15.2%
Q4 FY25₹370 Cr₹57 Cr15.3%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 49.83% of Rainbow Children'S Medicare Limited's shares as of Sept 2026, against 49.85% in Sept 2025 (−0.02 percentage points). Delivery averaged 53.1% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Rainbow Children'S Medicare Limited

Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children’s Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.

Products and Services

1. Medical and Healthcare Services-This segment offers medical and healthcare services comprising hospital services.

Business Segments

1. Rendering Medical and Healthcare Services.-100%

Rainbow Children'S Medicare Limited vs Peers — Hospitals and Healthcare Centers

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Apollo Hospitals Enterprise Limited₹1,23,712 Cr6321.50%₹7,615 Cr+11.6%
Max Healthcare Institute Ltd₹91,978 Cr63.914.33%₹2,569 Cr-16.6%
Manipal Health Enterprises Ltd₹89,110 Cr88.4—₹3,399 Cr—
Aster Dm Healthcare Limited (Asterdm)₹63,041 Cr97.610.07%₹2,829 Cr+4.3%
Fortis Healthcare Ltd.₹58,283 Cr55.111.01%₹2,735 Cr-25.1%
Global Health Ltd (Medanta)₹38,422 Cr69.715.03%₹1,469 Cr+16.2%
Narayana Hrudayalaya Limited₹37,907 Cr46.219.85%₹2,844 Cr+2.8%
Krishna Institute Of Medical Science (KIMS)₹29,056 Cr120.69.72%₹1,344 Cr+0.2%
Rainbow Children'S Medicare Limited₹13,010 Cr47.117.94%₹548 Cr-6.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Rainbow Children'S Medicare Limited?

Rainbow Children'S Medicare Limited is trading at ₹1,273.00, with a market capitalisation of ₹13,010 Cr.

Which sector does Rainbow Children'S Medicare Limited belong to?

Rainbow Children'S Medicare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).

What are the key financial ratios of Rainbow Children'S Medicare Limited?

Rainbow Children'S Medicare Limited has a P/E of 47.1 and a return on equity of 17.94%.

What is the stock symbol of Rainbow Children'S Medicare Limited?

Rainbow Children'S Medicare Limited is listed on the NSE under the symbol RAINBOW and on the BSE under the scrip code 543524.

How has Rainbow Children'S Medicare Limited's share price moved over the past year?

Rainbow Children'S Medicare Limited's share price is down 6.8% over one year and down 12.5% over three months. Its 52-week range is ₹1,084.00 to ₹1,610.00.

What were Rainbow Children'S Medicare Limited's latest quarterly results?

In Q2 FY27, Rainbow Children'S Medicare Limited reported revenue of ₹548 Cr and net profit of ₹84 Cr, with basic EPS of ₹8.1 (consolidated, parsed from the company's exchange filing).

How have Rainbow Children'S Medicare Limited's revenue and profit changed over the past year?

Rainbow Children'S Medicare Limited reported revenue of ₹548 Cr in Q2 FY27, up 23.2% from ₹445 Cr in Q2 FY26 and up 16.6% from ₹470 Cr in Q1 FY27.

What is the promoter holding in Rainbow Children'S Medicare Limited?

Promoters held 49.83% of Rainbow Children'S Medicare Limited's shares as of Sept 2026, against 49.85% in Sept 2025 (−0.02 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.